| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-3148.2012.01152.X |
| P698 | PubMed publication ID | 22591484 |
| P50 | author | John Moppett | Q61881736 |
| Simon Stanworth | Q28036972 | ||
| Robert F Wynn | Q57235361 | ||
| P2093 | author name string | Edwin Massey | |
| David I Marks | |||
| Brennan C Kahan | |||
| Effie Liakopoulou | |||
| Paula Bolton-Maggs | |||
| Ann Green | |||
| Geoff Lucas | |||
| Stephen P Robinson | |||
| Charlotte Llewelyn | |||
| Kay Harding | |||
| Deepak Sadani | |||
| P2860 | cites work | Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction | Q24241436 |
| Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project | Q33373051 | ||
| Prospective evaluation of the chemiluminescence test for the detection of granulocyte antibodies: comparison with the granulocyte immunofluorescence test | Q33492702 | ||
| Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions | Q33501221 | ||
| Return of granulocyte transfusions | Q33838838 | ||
| The measurement of performance in childhood cancer patients | Q34050319 | ||
| Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases | Q34102081 | ||
| Safety of granulocyte colony-stimulating factor in normal donors | Q34219512 | ||
| Granulocyte transfusion: a review | Q34368567 | ||
| Granulocyte concentrates: how can we assess their quality? | Q35583664 | ||
| Granulocyte transfusions in the G-CSF era. Where do we stand? | Q35845544 | ||
| Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma | Q37316074 | ||
| Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage | Q40489275 | ||
| Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors | Q40622888 | ||
| The Detection of Granulocyte Alloantibodies with an Indirect Immunofluorescence Test | Q40795932 | ||
| Granulocyte transfusion therapy: randomization after all? | Q42956275 | ||
| Cataracts in neutrophil donors stimulated with adrenal corticosteroids | Q43845927 | ||
| TRALI after the transfusion of cross-match-positive granulocytes | Q47361439 | ||
| Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia | Q47444445 | ||
| The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation | Q47612248 | ||
| Guidelines for compatibility procedures in blood transfusion laboratories | Q47885498 | ||
| Neutrophil function is preserved in a pooled granulocyte component prepared from whole blood donations. | Q50658148 | ||
| Storage of neutrophil granulocytes (PMNs) in additive solution or in autologous plasma for 72 h. | Q50764207 | ||
| Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients. | Q50768401 | ||
| Randomized phase III study of granulocyte transfusions in neutropenic patients. | Q50779342 | ||
| P433 | issue | 4 | |
| P921 | main subject | whole blood | Q7997549 |
| P304 | page(s) | 277-284 | |
| P577 | publication date | 2012-05-16 | |
| P1433 | published in | Transfusion Medicine | Q15758505 |
| P1476 | title | The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma | |
| P478 | volume | 22 |
| Q93378060 | An International Registry of Granulocyte Transfusions |
| Q39000687 | Characterization of buffy coat-derived granulocytes for clinical use: a comparison with granulocyte colony-stimulating factor/dexamethasone-pretreated donor-derived products. |
| Q91776206 | Granulocyte concentrates prepared from residual leukocyte units produced by the Reveos automated blood processing system |
| Q24186972 | Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction |
| Q24185847 | Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction |
| Q36286585 | Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies |
| Q47976914 | Granulocyte transfusions: A concise review for practitioners |
| Q38102420 | Granulocytes needed: how to collect? |
| Q53674609 | Guidelines on transfusion for fetuses, neonates and older children. |
| Q60932277 | Role of granulocyte transfusions in combating life-threatening infections in patients with severe neutropenia: Experience from a tertiary care centre in North India |
| Q47235713 | SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders. |
| Q38611890 | Use of granulocyte transfusions among haematology units in England and North Wales |
| Q48349038 | Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use. |
| Q92542973 | [Preparation of pooled granulocytes concentrates from whole blood buffy coats (PGC) as an alternative to apheresis] |
Search more.